With Dr. Maria Collazo-Clavell
Consultant, Division of Endocrinology, Diabetes, Metabolism & Nutrition at Mayo Clinic and is an Associate Professor at Mayo Clinic College of Medicine
Diabetes affects 25 million Americans at a total cost of $174 billion. In addition to diabetes-related complications and premature death, people with diabetes have medical expenditures approximately 2.3 times higher than those without diabetes. In this diabetes update we will share the latest recommendations for managing type 2 diabetes and:
- Discuss recent controversies surrounding DM2 management
- Identify HgbA1c, blood pressure and lipid management goals
- List third treatment options when metformin and sulfonylurea are insufficient
- Describe the role of incretin therapy in DM2 management
